Obesity and thyroid cancer risk: an update

F Franchini, G Palatucci, A Colao, P Ungaro… - International journal of …, 2022 - mdpi.com
Thyroid cancer (TC) is the most common endocrine malignancy worldwide and its incidence
has increased dramatically in recent years. In parallel, the prevalence of overweight and …

[HTML][HTML] CircRNA: A novel potential strategy to treat thyroid cancer

G Zhu, X Chang, Y Kang, X Zhao… - International …, 2021 - spandidos-publications.com
Thyroid cancer (TC) is the most common type of endocrine cancer. Over the last 50 years,
the global incidence of TC has been increasing. The survival rate of TC is higher than that of …

FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner

J Huang, W Sun, Z Wang, C Lv, T Zhang… - Journal of Experimental …, 2022 - Springer
Abstract Background N6-methyladenosine (m6A) modification is the most common chemical
modification in mammalian mRNAs, and it plays important roles by regulating several …

Circular RNA Circ_0067934 attenuates ferroptosis of thyroid cancer cells by miR-545-3p/SLC7A11 signaling

HH Wang, JN Ma, XR Zhan - Frontiers in endocrinology, 2021 - frontiersin.org
Ferroptosis is an emerging programmed cell death distinguished from apoptosis and
autophagy and plays essential roles in tumorigenesis. Thyroid cancer is a prevalent …

Selenium, selenoproteins and cancer of the thyroid

RM Rua, F Nogales, O Carreras, ML Ojeda - Journal of Trace Elements in …, 2023 - Elsevier
Selenium is an essential mineral element with important biological functions for the whole
body through incorporation into selenoproteins. This element is highly concentrated in the …

Thyroid nodule characterization: How to assess the malignancy risk. update of the literature

D Fresilli, E David, P Pacini, G Del Gaudio, V Dolcetti… - Diagnostics, 2021 - mdpi.com
Ultrasound (US) is the first imaging modality for thyroid parenchyma evaluation. In the last
decades, the role of ultrasound has been improved with the introduction of new US software …

Thyroid cancers: from surgery to current and future systemic therapies through their molecular identities

L Lorusso, V Cappagli, L Valerio, C Giani… - International Journal of …, 2021 - mdpi.com
Differentiated thyroid cancers (DTC) are commonly and successfully treated with total
thyroidectomy plus/minus radioiodine therapy (RAI). Medullary thyroid cancer (MTC) is only …

Molecular testing for thyroid nodules: the experience at McGill University teaching hospitals in Canada

M Rajab, RJ Payne, VI Forest, M Pusztaszeri - Cancers, 2022 - mdpi.com
Simple Summary The aim of this review is to provide a general overview about the
molecular markers (mutations and alterations) of thyroid cancers, present several molecular …

Cabozantinib, vandetanib, pralsetinib and selpercatinib as treatment for progressed medullary thyroid cancer with a main focus on hypertension as adverse effect

L Højer Wang, M Wehland, PM Wise… - International Journal of …, 2023 - mdpi.com
This manuscript investigates cabozantinib, vandetanib, pralsetinib, and selpercatinib, four
tyrosine kinase inhibitors (TKIs), which are used to treat advanced and/or metastatic …

Molecular markers guiding thyroid cancer management

C Nylén, R Mechera, I Maréchal-Ross, V Tsang… - Cancers, 2020 - mdpi.com
The incidence of thyroid cancer is rapidly increasing, mostly due to the overdiagnosis and
overtreatment of differentiated thyroid cancer (TC). The increasing use of potent preclinical …